Data on patients with multiple sclerosis and cranial nerve involvement as a presenting sign or a sign of disease exacerbation were retrospectively analyzed. Isolated cranial nerve involvement was present in 10.4% out of 483 patients, either as a presenting symptom (7.3%) or a symptom of disease relapse (3.1%). Trigeminal nerve was most frequently involved, followed by facial, abducens, oculomotor and cochlear nerves. Only 54% of patients had brainstem MRI lesion that could explain the symptoms. As multiple sclerosis is a disease characterized by multiple neurological symptoms, while early diagnosis and therapy are critical for the prognosis and course of the disease, the diagnosis of multiple sclerosis should be considered in young adults with cranial nerve involvement.
Introduction
Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central nervous system; however, several studies demonstrated peripheral nervous system involvement in a subgroup of patients 1, 2 . Although brainstem involvement is common at MS onset and during the course of the disease, isolated cranial nerve involvement is rare in MS patients. However, magnetic resonance imaging (MRI) may fail to visualize every symptomatic demyelinating lesion [3] [4] [5] .
In this study, data on clinically isolated syndrome (CIS) and MS patients with cranial nerve involvement as a presenting sign or a sign of disease exacerbation were retrospectively analyzed. Cranial nerve palsy was as a presenting sign was recorded in 35 (7.3%) patients: third nerve (n=2); fifth nerve (n=17) including trigeminal sensory neuropathy (n=9) and trigeminal neuralgia (n=8); sixth nerve (n=3); and seventh nerve (n=13) ( Table 1 ).
Patients and Methods

During
Cranial nerve palsy as a clinical sign of exacerbation was recorded in 15 (3.1%) patients:
fifth nerve (n=6) including trigeminal sensory neuropathy in 5 and trigeminal neuralgia in one patient; sixth nerve (n=2); seventh nerve (n=5); and eighth nerve (n=2).
Demyelinating brainstem lesion was found in 27 (54.0%) patients (Table 2) .
Study results showed third nerve involvement in 0.4%; fifth nerve involvement in 4.8%
(trigeminal neuralgia in 1.9% and trigeminal sensory neuropathy in 2.9%); sixth nerve palsy in 1.0%; seventh nerve palsy in 3.7%; and eighth nerve involvement in 0.4% of the CIS and MS patients.
Discussion
Although brainstem involvement is common during the course of MS, isolated cranial nerve palsies are rare. In the only study retrospectively investigating isolated cranial nerve palsy in MS, it was found in 1.6% of MS patients 3 . The authors conclude that isolated cranial nerve palsies more often occur as a presenting symptom than during disease relapse (p<0.001), which is consistent with our results. However, the mentioned study did not include patients with fifth nerve involvement, which was most frequently observed in our study patients. This may explain the difference in the rate of isolated cranial nerve involvement between these two patient cohorts. There are only few literature reports on particular cranial nerve involvement in MS.
Three large retrospective studies investigated the causes of third nerve involvement and only 1.7% of patients were found to have MS [8] [9] [10] . Although described in the literature, fourth nerve involvement was not recorded in our study. This could be explained by the fact that fascicular course of the trochlear nerve is at low myelin exposure 11 . Truly isolated sixth nerve palsy is also rare as a presenting sign of MS, with an incidence of 8, 9, 12 . These findings are especially important, as there is much debate in the literature on the use of MRI in patients with isolated third, fourth and sixth nerve palsies.
We argue that every patient with isolated lesions of these cranial nerves should undergo brain MRI as an initial diagnostic assessment, thus not to miss a serious pathology such as MS 13 .
Trigeminal neuralgia as the first manifestation of MS is reported in 0.3% and during the course of disease in 1.9% of cases [14] [15] [16] . Our study showed trigeminal sensory neuralgia in 1.9% of patients, either as the first sign or a relapse symptom. The pathogenetic mechanism of trigeminal sensory neuralgia in MS patients is usually caused by demyelinating lesions affecting pontine trigeminal pathways. Trigeminal sensory neuropathy secondary to MS preferentially affects the second and third division of the trigeminal nerve and was more common in our cohort than trigeminal neuralgia. Facial palsy was found as a presenting symptom in 19.6% and during the course of disease in 4.7% of Japanese patients with MS 17 . It was a rare symptom in our cohort, with a prevalence of 3.7%.
Eighth cranial nerve involvement is quite rare and only 0.4% of our patients suffered hearing loss as a symptom of MS. Some studies have shown that a demyelinating lesion in distal segment of the eighth cranial nerve may cause an acute hearing loss in MS 18 . As MS is a disease characterized by multiple neurological symptoms, while early diagnosis and therapy are critical for the prognosis and course of the disease, the diagnosis of MS should be considered in young adults with cranial nerve involvement. 
